1-5 of 5
Brenda Walker
Close
Sort by
Journal Articles

Expanded Access Program Of Ponatinib (AP24534) For Patients (Pts) With Refractory Chronic Myeloid Leukemia (CML) Or Philadelphia Chromosome-Positive (Ph+) Acute Lymphoblastic Leukemia (ALL)

Ghayathri Jeyakumar, MD, Hagop M. Kantarjian, MD, Kendra L. Sweet, MD, Cecilia Y Arana Yi, MD, Nitin Jain, MD, Elias Jabbour, MD, Alfonso Quintas-Cardama, MD, Susan O'Brien, MD, Brenda Walker, RN, Sherry R. Pierce, RN, BS, Tapan M. Kadia, MD, Farhad Ravandi, MD, Javier Pinilla, Jorge E. Cortes, MD
Journal: Blood
Blood (2013) 122 (21): 4044.
https://doi.org/10.1182/blood.V122.21.4044.4044
Published: 2013
Journal Articles

Memory Impairment in Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Patients (pts) Treated with Dasatinib Tyrosine Kinase Inhibitor (TKI) Therapy,

Naveen Pemmaraju, MD, Hagop M. Kantarjian, Maria F Tanaka, Susan O'Brien, MD, Elias Jabbour, Alfonso Quintas-Cardama, MD, Gautam Borthakur, Farhad Ravandi, MD, Srdan Verstovsek, MD, PhD, Elizabeth Burton, Brenda Walker, RN, Jorge E. Cortes
Journal: Blood
Blood (2011) 118 (21): 3771.
https://doi.org/10.1182/blood.V118.21.3771.3771
Published: 2011
Journal Articles

Results of a Phase II Trial of Dasatinib As Frontline Therapy for Chronic Myeloid Leukemia (CML) In Chronic Phase (CP)

Naveen Pemmaraju, MD, Hagop M. Kantarjian, Rajyalakshmi Luthra, PhD, Susan O'Brien, MD, Elias Jabbour, Alfonso Quintas-Cardama, MD, Gautam Borthakur, Farhad Ravandi, MD, Srdan Verstovsek, MD, PhD, Elizabeth Burton, Brenda Walker, RN, Jorge E. Cortes
Journal: Blood
Blood (2011) 118 (21): 1700.
https://doi.org/10.1182/blood.V118.21.1700.1700
Published: 2011
Journal Articles

Low Risk of Infectious Events in Patients (Pts) with Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) Treated with Dasatinib.

Ali M Al -Ameri, MD, Hagop Kantarjian, MD, Elizabeth Burton, Susan O'Brien, MD, Farhad Ravandi, M.D., Gautam Borthakur, MD, Brenda Walker, Mary Bath Rios, Jorge Cortes, MD
Journal: Blood
Blood (2009) 114 (22): 3291.
https://doi.org/10.1182/blood.V114.22.3291.3291
Published: 2009
Journal Articles

Efficacy of Dasatinib in Patients (pts) with Previously Untreated Chronic Myelogenous Leukemia (CML) in Early Chronic Phase (CML-CP).

Jorge Cortes, Gautam Borthakur, Susan O'Brien, M.D., Dan Jones, Elias Jabbour, Farhad Ravandi, MD, Charles Koller, Brenda Walker, Jenny Shan, Hagop Kantarjian
Journal: Blood
Blood (2009) 114 (22): 338.
https://doi.org/10.1182/blood.V114.22.338.338
Published: 2009